drugset / Trial / NCT01187498

Behavioral Treatment of Overactive Bladder in Men

NCT01187498

Phase 3 Completed 143 enrolled US Department of Veterans Affairs
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this project is to evaluate the effectiveness of behavioral treatment compared to standard drug therapy for symptoms of OAB in male veterans.

Timeline

Start
2005-01
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxybutynin Small molecule 10 mg

Indications